Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence
Open Access
- 15 August 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 49 (4) , 561-573
Abstract
Globally, ∼90% of new hepatitis C infections are attributed to injection drug use, but there is a continuing reluctance to treat injection drug usersKeywords
This publication has 64 references indexed in Scilit:
- High incidence of hepatitis C virus reinfection in a cohort of injecting drug usersHepatology, 2008
- Barriers associated with the treatment of hepatitis C virus infection among illicit drug usersDrug and Alcohol Dependence, 2008
- Limited Uptake of Hepatitis C Treatment Among Injection Drug UsersJournal of Community Health, 2007
- Referral for chronic hepatitis C treatment from a drug dependency treatment settingDrug and Alcohol Dependence, 2007
- Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implantsHepatology, 2007
- Duration of peginterferon therapy in acute hepatitis C: A randomized trialHepatology, 2006
- Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: The HEP-NET acute-HCV-II studyHepatology, 2006
- A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenanceHepatology, 2004
- Short-term interferon-alfa therapy for acute hepatitis C: A randomized controlled trialHepatology, 2004
- Diagnosis, management, and treatment of hepatitis C†Hepatology, 2004